Mesoblast (MEOBF) Receivables - Net (2015 - 2026)
Mesoblast's (MEOBF) quarterly Receivables - Net came in at $57.7 million in Q2 2026, up 287.86% year-over-year from $14.9 million in Q2 2025, and up 33.16% quarter-over-quarter from $43.3 million in Q4 2025.
Analysis
Mesoblast (MEOBF) Receivables - Net (2015 - 2026) Analysis & Trends
Mesoblast has disclosed Receivables - Net across 12 years of filings, most recently posting $57.7 million for Q2 2026.
- In Q2 2026, Receivables - Net rose 287.86% year-over-year to $57.7 million; the TTM figure through Jun 2026 stood at $57.7 million (up 287.86% YoY), while the FY2026 annual figure was $57.7 million, up 287.86% from the prior year.
- Receivables - Net came in at $57.7 million for Q2 2026 at Mesoblast, up from $43.3 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $57.7 million in Q2 2026 to a low of $3.0 million in Q4 2024.
- Average Receivables - Net over 5 years is $14.8 million, with a median of $6.3 million recorded in 2022.
- Year-over-year, Receivables - Net sank 31.35% in 2022 and jumped 1345.26% in 2025.
- Over 5 years, Receivables - Net stood at $5.1 million in 2022, then retreated by 21.84% to $4.0 million in 2023, then declined by 25.06% to $3.0 million in 2024, then jumped by 1345.26% to $43.3 million in 2025, then surged by 33.16% to $57.7 million in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $57.7 million in Q2 2026, $43.3 million in Q4 2025, and $14.9 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.66 Mn |
| Dec 31, 2025 | 43.30 Mn |
| Jun 30, 2025 | 14.87 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Jun 30, 2024 | 20.95 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 8.39 Mn |
| Dec 31, 2022 | 5.12 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 4.40 Mn |
| Mar 31, 2022 | 5.63 Mn |
| Dec 31, 2021 | 6.05 Mn |
| Sep 30, 2021 | 5.63 Mn |
| Jun 30, 2021 | 4.84 Mn |
| Mar 31, 2021 | 2.95 Mn |
| Dec 31, 2020 | 3.34 Mn |
| Sep 30, 2020 | 2.45 Mn |
| Jun 30, 2020 | 1.57 Mn |
| Mar 31, 2020 | 3.00 Mn |